Citrobacter freundii complex, and Serratia marcescens. Emblaveo is a fixed-dose intravenous (IV) treatment that combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback